MSL Centro
Pubblicato il 29-08-2026 - Jefferson Wells Italia in Reggio Emilia
Our client is a leading international biopharmaceutical company focused on developing and delivering innovative therapies for people living with rare and complex diseases. With a strong global presence and a patient‑centric approach, the company is committed to advancing scientific innovation and improving outcomes in areas of high unmet medical need.
La preghiamo di leggere attentamente i seguenti dettagli prima di inviare la sua candidatura.
The MSL (Emilia‑Romagna, Marche) is a field‑based scientific and subject‑matter expert for the assigned territory within the Medical Department, executing all assigned activities in accordance with Medical Excellence standards. The MSL is accountable to engage in non‑promotional, peer‑to‑peer, high quality scientific interactions with key external experts (KOLs) and other relevant HCPs / stakeholders, with the purpose of contributing to innovative healthcare partnerships and to improve the practice of medicine for better patient outcomes.
The MSL will act as the first point of contact in the field for medical/scientific aspects related to the assigned products/Therapeutic area (TA), working in close collaboration and synergy within the Medical Team.
Key responsibilities:
External Scientific Engagement:
-
- Serve as the primary field‑based medical and scientific expert, ensuring non‑promotional, peer‑to‑peer, high quality and balanced scientific interactions
- Develop effective and compliant scientific partnerships with KOLs/external experts and other relevant stakeholders (ie: PAGs representatives), while identifying opportunities to partner on disease awareness initiatives and/or collaborative research projects
- Contribute to the appropriate identification, characterization of key thought leaders (KOLs) /other relevant external stakeholders
Insight Generation & Strategic Contribution
-
- Be a strategic internal partner, gather and leverage insights for an impactful contribution in defining the local medical strategy an